Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
08/2005
08/11/2005US20050176905 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176763 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome
08/11/2005US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders
08/11/2005US20050176744 nitrogen heterocyclyl-(thio)carbonyl- quinoline derivatives used for treating cervical carcinoma or ovarian adenocarcinoma
08/11/2005US20050176724 2-Methyl-5-(2-{4-[3-(1-methylpiperidin-4-yl)benzyl]piperidin-1-yl}ethoxy)quinoline hydrochloride; antagonist of 5-serotonin (HT)1 type receptors;antidepressant and anxiolytic agent
08/11/2005US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050176698 Neuropeptide Y antagonists
08/11/2005CA2554525A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005CA2554522A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560574A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
08/10/2005EP1560488A2 Antibacterial agents
08/10/2005EP1086093B1 Tetrahydroquinoline derivatives as glycine antagonists
08/10/2005CN1652784A Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
08/10/2005CN1214009C antibacterial composition
08/09/2005US6927214 Non-peptide GLP-1 agonists
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/09/2005CA2105518C Condensed heterocyclic compounds, their production and use
08/04/2005WO2005070917A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070892A1 Amine salt of carbostyril derivative
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070890A2 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005070872A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists
08/04/2005WO2005070430A1 Quinoline derivatives and use thereof as mycobacterial inhibitors
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005019201A3 Process for the preparation of 4-amino-3-quinolinecarbonitriles
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2005000804A3 Substituted indoles and a process for preparing substituted indoles
08/04/2005WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors
08/04/2005WO2004091485A3 Aminoquinoline compounds
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171152 N-( alpha -ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide; neurokinin NK-3 receptor antagonists; chemical intermediates; efficient process with increased yields; coupling an ortho-hydroxy acid with an amine; easy conversion side-product to desired; CNC disorders; anxiolitic and antidepressant
08/04/2005US20050171138 Flavone acetic acid analogs and methods of use thereof
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders
08/04/2005US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553729A1 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
08/04/2005CA2551821A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1558594A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
08/03/2005EP1558587A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005EP1558565A2 Halogenated selective androgen receptor modulators and methods of use thereof
08/03/2005EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1648121A Quinoline deravative, preparing method and its use
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213036C Novel amide derivatives
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924295 Hetereocyclic amines such as 3-(5-(2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid ethyl ester, used as peroxisome proliferator activated receptor modulators; hyperlipemia; diabetis;
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b
08/02/2005CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
08/02/2005CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
07/2005
07/28/2005WO2005068429A1 Derivatives of pyridine and quinoline
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005US20050165235 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
07/28/2005US20050165095 preventing, treating or ameliorating retinoid poisoning, overdose by a retinoid; e.g. E-4-[3-(8,8-Dimethyl-5-p-tolyl-7,8-dihydro-naphthalen-2-yl)-3-hydroxyimino-propenyl]-benzoic acid (Compound 7a) and Z-4-[3-(8,8-dimethyl-5-p-tolyl-7,8-dihydro-naphthalen-2-yl)-3-hydroxyimino-propenyl]-benzoic Acid
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165062 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
07/28/2005US20050165054 Process for the preparation of quinoline derivatives
07/28/2005US20050165053 Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
07/28/2005US20050165052 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide
07/28/2005US20050165050 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
07/28/2005US20050165049 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders
07/28/2005US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide
07/28/2005US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165024 Urea derivatives as kinase modulators
07/28/2005DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
07/27/2005EP1556379A2 Chemical compounds
07/27/2005EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists
07/27/2005EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases
07/27/2005EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases
07/27/2005EP1343766B1 Cyclization process step in the making of quinolones and naphthyridines
07/27/2005EP0929526B1 Qinoline derivatives inhibiting the effect of growth factors such as vegf
07/27/2005CN1212317C Novel ester or amide derivatives
07/27/2005CN1212119C Organic compounds
07/26/2005US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV
07/26/2005CA2324848C Method of making camptothecin and camptothecin analogs
07/26/2005CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives
07/21/2005WO2005066132A1 Therapeutic agents i
07/21/2005WO2005066129A2 Bis-pyridino containing compounds for use in the treatment of cns pathologies
07/21/2005WO2005066116A1 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 277